Fact : Unfortunately, this is not always the case
DURATION diabetes therapy utilization: researching changes in A1C, weight and other factors through intervention with exenatide QW (extended-release exenatide, 2 mg, once weekly), EQW exenatide QW, HDL-C high density lipoprotein cholesterol, GLP-1 RA glucagon-like peptide-1 receptor agonist, LDL-C low density lipoprotein cholesterol, RCTs randomised controlled trials, T2DM type 2 diabetes mellitus, TZD thiazolidinediones Table 15
Short-term risks may include: Potential longer-term complications are: Recovery takes time
Emergency Care In a life-threatening medical emergency, every second counts
The second pathway requires a BMI greater than 30 combined with at least one of the following: uncontrolled hypertension, advanced kidney disease, or heart failure
That's exactly right